Mountain town confronts an unexpected public health catastrophe

Before Hurricane Helene, had you stopped by one of the many breweries, art galleries, or award-winning restaurants in Asheville, North Carolina, and spoken with anyone who lives in these parts — including me — most would have told you they felt pretty safe from climate disasters.

Bristol Myers pays $350M upfront for rights to heart drug Camzyos in Asia

Bristol Myers Squibb is setting up a deal with Shanghai-based LianBio to get the rights to the heart drug Camzyos in China and several other

October 25, 2023

Boehringer reinforces interest in NASH with new $2bn deal – Pharmaceutical Technology

Share this article Boehringer will use Ribo’s RIBO-GalSTAR platform to identify and develop therapies for NASH. Credit: Michael Vi via Shutterstock. Boehringer Ingelheim is intensifying

January 3, 2024

Atezolizumab by F. Hoffmann-La Roche for Urethral Cancer: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.